Uttam Chanda – Zte Corporation
View Detailed Executive Profile →Professional Overview
- Uttam Chanda co-founded Heisenberg Pharmaceuticals in November 2019, contributing to the development of innovative solutions in the pharmaceutical sector.
- Under the leadership of Uttam Chanda, Heisenberg Pharmaceuticals focused on integrating cutting-edge technology with traditional pharmaceutical practices to enhance drug efficacy.
- Uttam Chanda played a pivotal role in securing funding and investments crucial for the initial growth phases of Heisenberg Pharmaceuticals.
- The organization successfully launched several clinical trials under the guidance of Uttam Chanda, expanding their product pipeline significantly.
- Uttam Chanda led initiatives to ensure that the company's research adheres to regulatory standards, thereby maintaining high ethical practices in clinical testing.
- As a co-founder, Uttam Chanda facilitated partnerships with academic institutions, enhancing research capabilities through collaborative projects.
- In the face of industry challenges, Uttam Chanda adapted strategic business approaches to navigate market fluctuations effectively.
- Uttam Chanda’s commitment to innovation helped establish a strong brand identity for Heisenberg Pharmaceuticals within a competitive landscape.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Heisenberg pharmaceuticals | Co-Founder | Nov 2019 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Zte Corporation corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Uttam Chanda's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Zte Corporation's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)